• A Case Report of Cardiofaciocutaneous Syndrome with <em>MAP2K1</em> Pathogenic Variant
• A Case Report of Cardiofaciocutaneous Syndrome with MAP2K1 Pathogenic Variant
• A Case Report of Cardiofaciocutaneous Syndrome with MAP2K1 Pathogenic Variant [Letter]
• An Unusual Presentation of Cardiofaciocutaneous Syndrome Diagnosed Through Whole Genome Sequencing: A Case Report
• Analysis of the Oral Microbiome in a Patient with Cardiofaciocutaneous Syndrome and Severe Periodontal Disease: Impact of Systemic Antibiotic Therapy
• Bone health in RASopathies
• Cardiofaciocutaneous Syndrome
• Case report: Gastroenterological management in a case of cardio-facio-cutaneous syndrome
• Central nervous system involvement in individuals with RASopathies
• Clinical overview on RASopathies
• Dermatological manifestations in Costello syndrome: A prospective multicentric study of 31 HRAS-positive variant patients
• Dermatological manifestations, management, and care in RASopathies
• Dermoscopic Features of Melanocytic Nevi in Cardiofaciocutaneous and Costello Syndromes
• Diverse Clinical Manifestations of Cardiofaciocutaneous Syndrome Type 3 in Two Patients from South East Asia
• Endocrine system involvement in patients with RASopathies: A case series
• Epilepsy in cardiofaciocutaneous syndrome: Clinical burden and response to anti-seizure medication
• Evolutionary history of MEK1 illuminates the nature of deleterious mutations
• Genotypic Findings in Noonan and Non-Noonan RASopathies and Patient Eligibility for Growth Hormone Treatment
• Infantile epileptic spasms syndrome in children with cardiofaciocutanous syndrome: Clinical presentation and associations with genotype
• Long-term clinical course of adult-onset refractory epilepsy in cardiofaciocutaneous syndrome with a pathogenic MAP2K1 variant: a case report
• Management of nutritional and gastrointestinal issues in RASopathies: A narrative review
• MEK Inhibition for RASopathy-Associated Hypertrophic Cardiomyopathy: Clinical Application of a Basic Concept
• Molecular and phenotypic spectrum of cardio-facio-cutaneous syndrome in Chinese patients
• Natural history and outcomes in paediatric RASopathy-associated hypertrophic cardiomyopathy
• New prospectives on treatment opportunities in RASopathies
• Novel Use of Intranasal Dexmedetomidine for Refractory Irritability in Pediatric Home Care
• Phenotypic Features in a New 12q21 Deletion and Its Association With Cardiofaciocutaneous Syndrome
• Prenatal and infantile diagnosis of craniosynostosis in individuals with RASopathies
• RASopathies for Radiologists
• Skeletal defects and bone metabolism in Noonan, Costello and cardio-facio-cutaneous syndromes
• Small molecule inhibition for RASopathy-associated hypertrophic cardiomyopathy: Clinical application of a basic concept
• Spontaneous haemopericardium due to vitamin K deficiency in an adult patient with cardiofaciocutaneous syndrome
• Status epilepticus in BRAF-related cardio-facio-cutaneous syndrome: Focus on neuroimaging clues to physiopathology
• The "FEEDS (FEeding Eating Deglutition Skills)" over Time Study in Cardiofaciocutaneous Syndrome
• The Cardiofaciocutaneous Syndrome: From Genetics to Prognostic-Therapeutic Implications
• Treatment of Refractory Epilepsy With MEK Inhibitor in Patients With RASopathy
• Whole exome sequencing based identification of a case of cardiofaciocutaneous syndrome type 3: the benefits of new sequencing technology in children with neurodevelopmental delay